株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

米国の性行為感染症(STD)検査市場の分析:軟性下疳、クラミジア、淋病、ヘルペス、HPV、梅毒

2016-2020 Emerging US Sexually-Transmitted Disease Testing Market: Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, Syphilis--Supplier Shares by Test, Competitive Strategies, Country Volume and Sales Segment Forecasts

発行 Venture Planning Group 商品コード 273952
出版日 ページ情報 英文 278 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.77円で換算しております。

Local License: 同一事業所内

Back to Top
米国の性行為感染症(STD)検査市場の分析:軟性下疳、クラミジア、淋病、ヘルペス、HPV、梅毒 2016-2020 Emerging US Sexually-Transmitted Disease Testing Market: Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, Syphilis--Supplier Shares by Test, Competitive Strategies, Country Volume and Sales Segment Forecasts
出版日: ページ情報: 英文 278 Pages
概要

当レポートでは、米国の性行為感染症(STD)検査市場について調査分析し、新興の検査、技術、検査用装置について検証し、売上高予測、市場シェア、主要サプライヤーの戦略的プロファイルを提供して、概略以下の構成でお届けいたします。

イントロダクション

世界市場と技術の概要

  • 主要な感染症検査
    • 軟性下疳
    • クラミジア
    • 淋病
    • 単純ヘルペスウイルス
    • ヒトヘルペスウイルス6型(HHV-6)
    • パピローマウイルス(HPV)
    • 梅毒
  • 検査用装置レビュー
  • 新興の診断技術
    • 分子診断
    • モノクローナル抗体
    • イムノアッセイ
    • 差分光散乱
    • IT
    • 人工知能
    • リポソーム
    • フローサイトメトリー
    • クロマトグラフィー
    • 画像診断
    • ゲル微液滴
    • その他

米国:市場規模、成長率、主要サプライヤーの売上高と市場シェア

代替的な市場浸透戦略

  • 国内開発
  • 共同事業協定
  • 大学との契約
  • 流通戦略

潜在的な市場参入障壁とリスク

  • 市場の成熟
  • 費用抑制
  • 競合
  • 技術面での優位性と限界
  • 特許権保護
  • 規制上の制約
  • 分散型検査市場の課題

競合評価

  • Abbott
  • Affymetrix
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Diamedix
  • DiaSorin
  • 栄研化学
  • Enzo Biochem
  • 富士レビオ/Innogenetics
  • Hologic/Gen-Probe
  • ID Biomedical/GSK
  • Kreatech
  • Life Technology
  • Lonza
  • Nanogen/Elitech
  • Novartis Diagnostics
  • Ortho-Clinical Diagnostics
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • SeraCare
  • Siemens
  • タカラバイオ
  • Thermo Fisher
  • Wallac/PE
  • 和光純薬工業

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: VPID16725

This new 278-page report from VPGMarketResearch.com provides analysis of the US sexually-transmitted disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.

The report presents detailed analysis of the STD market in the US, Current scientific views on epidemiology and etiology are presented for Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, and Syphilis. The report provides test volume and sales forecasts and market segment, including:

     - Hospitals
     - Commercial/Private Labs
     - Physician Offices
     - Public Health Labs      

In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of STD diagnostic products, by test.  Also, the report:

     -  Examines market applications of Molecular Diagnostics,  
        Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;

     -  Reviews features and operating characteristics of major analyzers used 
        for STD testing;

     -  Profiles key suppliers and potential market entrants developing innovative
        technologies and products; and

     -  Analyzes emerging opportunities, alternative market penetration strategies, 
         market entry barriers/risks, and strategic planning issues.

Methodology

The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products in the US.

In addition to primary sources of information, a comprehensive review of
the most recent technical and business publications, manufacturer product
and financial literature, as well as VPGMarketResearch’s proprietary data files was conducted.
 
Contains 278 pages and 18 tables

Table of Contents

Introduction

Worldwide Market and Technology Overview

  • A. Major Infectious Disease Tests
    • 1. Chancroid
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 2. Chlamydia
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 3. Gonorrhea
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 4. Herpes Simplex Virus
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • Human Herpes Virus-6 (HHV-6)
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 5. Papillomavirus (HPV)
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 6. Syphilis
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
  • B. Instrumentation Review of Leading Analyzers Marketed by Abbott, Beckman Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers
  • C. Emerging Diagnostic Technologies
    • 1. Molecular Diagnostics
    • 2. Monoclonal Antibodies
    • 3. Immunoassays
    • 4. Differential Light Scattering
    • 5. Information Technology
    • 6. Artificial Intelligence
    • 7. Liposomes
    • 8. Flow Cytometry
    • 9. Chromatography
    • 10. Diagnostic Imaging
    • 11. Gel Microdroplets
    • 12. Other

USA: Market Size, Growth and Major Suppliers' Sales and Market Shares

Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
  • D. Distribution Strategies for Decentralized Testing Markets
    • 1. Marketing Approaches
    • 2. Product Complexity
    • 3. Customer Preference
    • 4. Established Suppliers
    • 5. Emerging Suppliers
    • 6. Major Types of Distributors
    • 7. Market Segmentation

Potential Market Entry Barriers and Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge and Limitations
  • E. Patent Protection
  • F. Regulatory Constraints
  • G. Decentralized Testing Market Challenges

Competitive Assessments

  • Abbott
  • Affymetrix
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Diamedix
  • DiaSorin
  • Eiken Chemical
  • Enzo Biochem
  • Fujirebio/Innogenetics
  • Hologic/Gen-Probe
  • ID Biomedical/GSK
  • Kreatech
  • Life Technology
  • Lonza
  • Nanogen/Elitech
  • Novartis Diagnostics
  • Ortho-Clinical Diagnostics
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • SeraCare
  • Siemens
  • Takara Bio
  • Thermo Fisher
  • Wallac/PE
  • Wako

List of Tables

  • Major Companies Developing or Marketing Chlamydia Tests
  • Major Companies Developing or Marketing Gonorrhea Tests
  • Major Companies Developing or Marketing Herpes Tests
  • Major Companies Developing or Marketing Pap Smear/HPV Tests
  • Major Companies Developing or Marketing Syphilis Tests
  • U.S.A.
  • Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Chancroid Diagnostics Sales by Major Supplier
  • U.S.A.
  • Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Chlamydia Diagnostics Sales by Major Supplier
  • U.S.A.
  • Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Gonorrhea Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Herpes Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Syphilis Testing Market Diagnostics Sales by Major Supplier
Back to Top